Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Einfluss von Alter, Geschlecht und kardialer Grunderkrankung auf den Anstieg der Sinusknotenfrequenz bei Patienten mit VDD Schrittmachern im Langzeitverlauf.
Schuchert A, Jakob M, Treese N, Schmidt W, Jung W, Karmann W, Kreuzer J, Staedt U, Stertmann WA, Meinertz T. Schuchert A, et al. Among authors: karmann w. Herzschrittmacherther Elektrophysiol. 1998 Feb;9 Suppl 1:75-6. doi: 10.1007/BF03042446. Herzschrittmacherther Elektrophysiol. 1998. PMID: 19484557 German. No abstract available.
Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.
Ungethüm K, Wiedmann S, Wagner M, Leyh R, Ertl G, Frantz S, Geisler T, Karmann W, Prondzinsky R, Herdeg C, Noutsias M, Ludwig T, Käs J, Klocke B, Krapp J, Wood D, Kotseva K, Störk S, Heuschmann PU. Ungethüm K, et al. Among authors: karmann w. Clin Res Cardiol. 2023 Feb;112(2):285-298. doi: 10.1007/s00392-022-02093-0. Epub 2022 Sep 27. Clin Res Cardiol. 2023. PMID: 36166067 Free PMC article.
Physicians' lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV.
Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU; STAAB Consortium. Tiffe T, et al. Among authors: karmann w. Eur J Prev Cardiol. 2021 Sep 20;28(11):1175-1183. doi: 10.1177/2047487319838218. Epub 2019 Mar 19. Eur J Prev Cardiol. 2021. PMID: 37039762
Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey.
Goettler D, Wagner M, Faller H, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Heuschmann PU, Störk S; German EUROASPIRE IV collaborators. Goettler D, et al. Among authors: karmann w. BMC Cardiovasc Disord. 2020 Mar 30;20(1):152. doi: 10.1186/s12872-020-01429-w. BMC Cardiovasc Disord. 2020. PMID: 32228474 Free PMC article.
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.
Ferrannini G, De Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D, Rydén L; EUROASPIRE V collaborators. Ferrannini G, et al. Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20. Diabetes Care. 2020. PMID: 32079627
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk. De Backer G, et al. Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24. Atherosclerosis. 2019. PMID: 31054483
17 results